KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Bionano Genomics (BNGO) Return on Invested Capital (2018 - 2025)

Bionano Genomics' Return on Invested Capital history spans 7 years, with the latest figure at 0.72% for Q3 2025.

  • For Q3 2025, Return on Invested Capital rose 99.0% year-over-year to 0.72%; the TTM value through Sep 2025 reached 0.72%, up 99.0%, while the annual FY2024 figure was 1.49%, 28.0% down from the prior year.
  • Return on Invested Capital for Q3 2025 was 0.72% at Bionano Genomics, up from 1.43% in the prior quarter.
  • Across five years, Return on Invested Capital topped out at 0.14% in Q2 2021 and bottomed at 2.26% in Q4 2024.
  • The 5-year median for Return on Invested Capital is 0.65% (2023), against an average of 1.0%.
  • The largest annual shift saw Return on Invested Capital skyrocketed 162bps in 2021 before it crashed -166bps in 2024.
  • A 5-year view of Return on Invested Capital shows it stood at 0.21% in 2021, then tumbled by -137bps to 0.5% in 2022, then tumbled by -290bps to 1.93% in 2023, then decreased by -17bps to 2.26% in 2024, then surged by 68bps to 0.72% in 2025.
  • Per Business Quant, the three most recent readings for BNGO's Return on Invested Capital are 0.72% (Q3 2025), 1.43% (Q2 2025), and 1.79% (Q1 2025).